Renal atrophy following gated delivery of stereotactic ablative radiotherapy to adrenal metastases

Stereotactic ablative radiotherapy (SABR) planning for adrenal metastases aims to minimize doses to the adjacent kidney. Renal dose constraints for SABR delivery are not well defined. In 20 patients who underwent MR-guided breath-hold SABR in five daily fractions of 8–10 Gy, ipsilateral renal volume...

Full description

Saved in:
Bibliographic Details
Published in:Physics and imaging in radiation oncology 2021-10, Vol.20, p.1-4
Main Authors: van Sörnsen de Koste, John R., van Vliet, Claire C., Schneiders, Famke L., Bruynzeel, Anna M.E., Slotman, Berend J., Palacios, Miguel A., Senan, Suresh
Format: Article
Language:English
Subjects:
Adrenal
Kidney
Organ at Risk
Renal dose constraints
SABR
Short Communication
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Stereotactic ablative radiotherapy (SABR) planning for adrenal metastases aims to minimize doses to the adjacent kidney. Renal dose constraints for SABR delivery are not well defined. In 20 patients who underwent MR-guided breath-hold SABR in five daily fractions of 8–10 Gy, ipsilateral renal volumes receiving ≥20 Gy best correlated with loss of renal volumes, with median renal volume reduction being 6% (range: 3%-11%, 10th-90th percentiles). Organ function did not deteriorate in 18 patients, who had post treatment renal function tests available. This suggests that the ipsilateral renal volume receiving 20 Gy can be used as partial organ dose constraint for SABR to targets in the upper abdomen.
ISSN:2405-6316
2405-6316
DOI:10.1016/j.phro.2021.09.001